Publications

Selected Publications

Mapunda, J. A.; Laverty, D. J.; Aziz, F. Le, A; Sangare, J.; Zhang, L.; Nagel, Z. D.; French, J. B. Sarkaria, J. N.; Kitange, G. J. "Pharmacologic inhibition of RBBP4/p300-mediated homologous recombination activity enhances glioblastoma sensitivity to temozolomide" Neuro-Oncology Advances 2026

Zhai, T; Cheong, A; Laverty, D. J. and Nagel, Z. D. "MSIanalyzer: Targeted Nanopore Sequencing Enables Single Nucleotide Resolution Analysis of Microsatellite Instability Diversity" Journal of Molecular Biology 2026

Laverty, D. J.; Tomar, R.; Erlich, S.; Stone, M. P.; Nagel, Z. D. "The Aflatoxin B1-Induced Formamidopyrimidine Adduct is Repaired by Transcription-Coupled Nucleotide Excision Repair in Human Cells" NAR Cancer 2025

Punzi, S. et. al. "Early tolerance and late persistence as alternative drug responses in cancer" Nature Communications 2025

Laverty, D. J.; Gupta, S. K.; Bradshaw, G, A.; Hunter, A. S.; Carlson, B. L.; Matias Calmo, N.; Chen, J.; Tian, S.; Sarkaria, J. N.; Nagel, Z. D. “ATM Inhibition Exploits Checkpoint Defects and ATM-Dependent Double Strand Break Repair in TP53-Mutant Glioblastoma.” Nature Communications 2024

Chen, J.; Laverty, D. J. et. al. "Aberrant ATM signaling and homology-directed DNA repair as a vulnerability of p53-mutant GBM to AZD1390-mediated radiosensitization" Science Translational Medicine 2024

Rona, G. et. al. "CDK-independent role of D-type cyclins in regulating DNA mismatch repair" Molecular Cell 2024

Laverty, D. J.; Mortimer, I. F.; Greenberg, M. M. “Mechanistic Insight Through Irreversible Inhibition: DNA Polymerase Theta Uses a Common Active Site for Polymerase and Lyase Activities.” Journal of The American Chemical Society 2018

For a complete list, see: https://www.researchgate.net/profile/Daniel-Laverty